School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Charles Lorentz

  • Department of Urology
    Assistant Professor
  • (404) 778-2524
Head shot of Charles Lorentz

Overview

Dr. Adam Lorentz is an Assistant Professor of Urology at the Emory University School of Medicine and Chief of Urology at Emory University Hospital Midtown. He graduated from the Honors Program at the University of Georgia with Bachelor of Science degrees in Genetics and Psychology. He attended medical school at the Emory University School of Medicine, where he participated widely in volunteer service locally and abroad, including work with the Emory Haiti Alliance. He went on to complete his internship and residency training at Emory and joined Emory Urology as a faculty member in 2018. His clinical interests include urologic cancers, benign prostatic hyperplasia (BPH), kidney stone disease, and minimally invasive surgery.

Dr. Lorentz has been recognized for excellence in both academics and patient care. He was awarded the William Hollis Cooner Award for exemplary compassion and patient care as well as the Montague Boyd research award from the Southeastern Section of the American Urological Association. He's been recognized by his peers with the Hidden Gem award, calling him "a consummate physician leader who is esteemed by his team, his colleagues and his patients alike."

Dr. Lorentz is an experienced robotic surgeon and the first urologist in Atlanta to perform single-port robotic surgery using the advanced Da Vinci SP platform. This allows for less-invasive approaches to common urological surgeries, including extraperitoneal prostate and kidney surgery. He also offers focal therapy for prostate cancer, having performed the first High-Intensity Focused Ultrasound (HIFU) prostate ablation treatments at Emory. He strives to bring the most current treatments to his patients for improving quality of life, such as penile prosthesis and benign prostate treatments like Aquablation and UroLift. He is involved in mentoring medical students and residents. His research has earned numerous awards; he has co-authored over 35 peer-reviewed scientific journal articles and abstracts, which have been presented locally, nationally, and internationally. As Medical Director of The Emory Clinic Urology at Emory University Hospital Midtown, Co-Director of the Community Division of Emory Urology, and Medical Director for Emory Healthcare Patient Access, Dr. Lorentz is working to expand access to urologic care in Atlanta and the surrounding communities. He serves as Chief of Urology at Emory University Hospital Midtown.

Academic Appointment

  • Assistant Professor, Urology, Emory University Hospital Midtown

Education

Degrees

  • MD from Emory University
  • BS from University of Georgia

Research

Publications

  • Utilization, health care expenditures, and patient costs of definitive treatment modalities for localized prostate cancer in the United States.
    Cancer Volume: 131 Page(s): e35795
    03/15/2025 Authors: Sebastian NT; Patil D; Patel PR; Jani AB; Hershatter BW; Dhere VR; Godette KD; Lorentz CA; Weiss AD; Joshi SS
  • Development of Patient-Specific Nomogram to Assist in Clinical Decision-Making for Single Port Versus Multi-Port Robotic Partial Nephrectomy: A Report from the Single Port Advanced Robotic Consortium.
    J Endourol Volume: 39 Page(s): 252 - 260
    03/01/2025 Authors: Soputro NA; Okhawere KE; Ramos-Carpinteyro R; Sauer Calvo R; Wang Y; Manfredi C; Snajdar E; Raver M; Saini I; Chavali JS
  • Risk of Readmission After Uncomplicated Hospitalization After Radical Cystectomy.
    Clin Genitourin Cancer Volume: 16 Page(s): e705 - e710
    08/01/2018 Authors: Lorentz CA; Gilbert K; Alemozaffar M; Patil D; Filson CP
  • Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).
    Urol Oncol Volume: 36 Page(s): 79.e11 - 79.e17
    02/01/2018 Authors: Tilki D; Chandrasekar T; Capitanio U; Ciancio G; Daneshmand S; Gontero P; Gonzalez J; Haferkamp A; Hohenfellner M; Huang WC
  • Predictive Nomogram for Recurrence following Surgery for Nonmetastatic Renal Cell Cancer with Tumor Thrombus.
    J Urol Volume: 198 Page(s): 810 - 816
    10/01/2017 Authors: Abel EJ; Masterson TA; Karam JA; Master VA; Margulis V; Hutchinson R; Lorentz CA; Bloom E; Bauman TM; Wood CG
  • Myosin light chain kinase knockout improves gut barrier function and confers a survival advantage in polymicrobial sepsis.
    Mol Med Volume: 23 Page(s): 155 - 165
    08/01/2017 Authors: Lorentz CA; Liang Z; Meng M; Chen C-W; Yoseph BP; Breed ER; Mittal R; Klingensmith NJ; Farris AB; Burd EM
  • Implementation of a Tele-urology Program for Outpatient Hematuria Referrals: Initial Results and Patient Satisfaction.
    Urology Volume: 97 Page(s): 33 - 39
    11/01/2016 Authors: Safir IJ; Gabale S; David SA; Huang JH; Gerhard RS; Pearl J; Lorentz CA; Baumgardner J; Filson CP; Issa MM
  • Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival.
    J Surg Oncol Volume: 114 Page(s): 764 - 768
    11/01/2016 Authors: Mager R; Daneshmand S; Evans CP; Palou J; Martnez-Salamanca JI; Master VA; McKiernan JM; Libertino JA; Haferkamp A; International Renal Cell Carcinoma-Venous Thrombus Consortium
  • Renal cell carcinoma with vena caval involvement: a contemporary clinicopathologic analysis of 53 cases.
    Hum Pathol Volume: 49 Page(s): 83 - 89
    03/01/2016 Authors: Nwadei IU; Lorentz A; Patil D; Dimarco MA; Master VA; Osunkoya AO
  • Predicting Length of Stay Following Radical Nephrectomy Using the National Surgical Quality Improvement Program Database.
    J Urol Volume: 194 Page(s): 923 - 928
    10/01/2015 Authors: Lorentz CA; Leung AK; DeRosa AB; Perez SD; Johnson TV; Sweeney JF; Master VA
  • Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy.
    J Urol Volume: 193 Page(s): 436 - 442
    02/01/2015 Authors: Tilki D; Hu B; Nguyen HG; Dall'Era MA; Bertini R; Carballido JA; Chandrasekar T; Chromecki T; Ciancio G; Daneshmand S
  • Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.
    Eur Urol Volume: 66 Page(s): 577 - 583
    09/01/2014 Authors: Tilki D; Nguyen HG; Dall'Era MA; Bertini R; Carballido JA; Chromecki T; Ciancio G; Daneshmand S; Gontero P; Gonzalez J
  • Inherent difficulties of measuring the burden of surgical disease in resource-poor settings.
    World J Surg Volume: 37 Page(s): 2248 - 2249
    09/01/2013 Authors: Leeds IL; Hugar LA; Lorentz CA; Srinivasan J; Pattaras JG; Master VA
  • IMPACT OF HISTOLOGIC SUBTYPE ON TUMOR THROMBUS LEVEL AND CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA AND VENA CAVA THROMBUS

    Authors: Tilki D; Dall'Era MA; Nguyen HG; Bertini R; Carballido JA; Chromecki T; Ciancio G; Daneshmand S; Gontero P; Gonzalez J
  • LEVEL OF THROMBOUS ACCORDING TO MAYO CLINIC CLASSIFICATION IS AN INDEPENDENT PREDICTOR OF PERIOPERATIVE COMPLICATIONS AND CANCER-RELATED OUTCOME: DATA OF THE IRCVT RCC VENOUS THROMBUS CONSORTIUM

    Authors: Martinez-Salamanca JI; Novara G; Bertini R; Carballido J; Chromecki T; Ciancio G; Daneshmand S; Evans C; Gontero P; Gonzalez J
  • IMPACT OF MICROSCOPIC VEIN INVASION ON CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA AND TUMOR THROMBUS

    Authors: Rodriguez Faba O; Martinez Salamanca JI; Tilki D; Dall'Era MA; Nguyen HG; Roberto B; Carballido JA; Chromecki T; Ciancio G; Daneshmand S
  • DOES THE USE OF CARDIOPULMONARY BY-PASS (CPB) IMPACT SURVIVAL IN PATIENTS UNDERGOING NEPHRECTOMY/LEVEL III-IV TUMOR THROMBECTOMY? A MULTI-INSTITUTIONAL ANALYSIS

    Authors: Hao N; Tilki D; Dall'Era M; Bertini R; Carballido J; Chromecki T; Ciancio G; Daneshmand S; Gontero P; Gonzalez J
  • CANCER-SPECIFIC SURVIVAL AND PREDICTORS IN PATIENTS WITH CT3B KIDNEY CANCER: DATA OF THE IRCVT RCC VENOUS THROMBUS CONSORTIUM

    Authors: Linares E; Martinez-Salamanca JI; Novara G; Bertini R; Carballido J; Chromecki T; Ciancio G; Daneshmand S; Evans C; Gontero P
  • THE SIGNIFICANCE OF SYMPTOMATOLOGY: ANALYSIS FROM THE INTERNATIONAL RENAL CELL CARCINOMA-VENOUS THROMBUS CONSORTIUM (IRCC-VTC)

    Authors: Pak JS; Lascano D; Finkelstein JB; McKiernan JM; DeCastro GJ; Capitanio U; Carballido JA; Chantada V; Chromecki T; Ciancio G
  • MULTICENTER VALIDATION OF PREDICTIVE MODEL FOR POSTSURGICAL RECURRENCE IN NON-METASTATIC RCC WITH THROMBUS

    Authors: Blute ML; Masterson TA; Master VA; Margulis V; Lorentz A; Bauman T; Zorn K; Karam JA; Wood CG; Abel EJ
  • NOMOGRAM TO PREDICT RECURRENCE IN NON-METASTATIC RCC WITH THROMBUS USING A MULTI-CENTER CONTEMPORARY SERIES

    Authors: Blute ML; Masterson TA; Master VA; Margulis V; Lorentz CA; Bauman TM; Karam JA; Wood CG; Abel EJ
  • PROLONGED LENGTH OF STAY NOT ASSOCIATED WITH DECREASED HOSPITAL READMISSIONS FOLLOWING UNCOMPLICATED HOSPITALIZATION AFTER RADICAL CYSTECTOMY

    Authors: Gilbert K; Lorentz A; Patil D; Alemozaffar M; Filson C
  • Genomic Mapping of Primary Unifocal and Multifocal Renal Cell Carcinoma

    Authors: Obeng RC; Lorentz A; Alqassab U; Laganosky D; Keith C; Lian F; Ogan K; Master VA; Pattaras JG; Rossi M
  • Genomic Mapping of Primary Unifocal and Multifocal Renal Cell Carcinoma

    Authors: Obeng RC; Lorentz A; Alqassab U; Laganosky D; Keith C; Lian F; Ogan K; Master VA; Pattaras JG; Rossi M
  • Utility of preoperative inflammatory markers for prognosis in patients with renal cell carcinoma and vena cava tumor thrombus

    Authors: Lorentz CA; Jafri SMA; Tai CG; Herrel LA; Master VA
  • A Clinicopathologic Analysis of 53 Cases of Renal Cell Carcinoma With Vena Caval Involvement

    Authors: Nwadei I; Lorentz A; Master V; Osunkoya A
  • Clinicopathologic Analysis of 53 Cases of Renal Cell Carcinoma With Vena Caval Involvement

    Authors: Nwadei I; Lorentz A; Master V; Osunkoya A
  • MYOSIN LIGHT CHAIN KINASE KNOCKOUT CONFERS A SURVIVAL ADVANTAGE IN POLYMICROBIAL SEPSIS ASSOCIATED WITH UPREGULATION OF ZO-1 AND CLAUDIN-15

    Authors: Lorentz AC; Liang Z; Mittal R; Coopersmith CM
  • THE ROLE OF MLCK IN SEPSIS-INDUCED INTESTINAL HYPERPERMEABILITY

    Authors: Lorentz CA; Yoseph BP; Breed ER; Liang Z; Mittal R; Coopersmith C
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2024 Emory University
  • Privacy Policy
  • Emergency Information